(MET(O)4,D-LYS8,PHE9)-ACTH (4-9) is a synthetic peptide that emulates the structure and function of the naturally occurring adrenocorticotropic hormone (ACTH). It encompasses the amino acid sequence from positions 4 to 9 of the ACTH peptide, with modifications including a methionine sulfoxide group at position 4 and D-lysine and phenylalanine at positions 8 and 9, respectively. These alterations enhance the peptide's stability and bioactivity, rendering it a valuable asset for research into the physiological and pharmacological impacts of ACTH.
50913-93-4
Post Buying Request-
-
Basic information
- Product Name: (MET(O)4,D-LYS8,PHE9)-ACTH (4-9)
- Synonyms: MET(O)-GLU-HIS-PHE-D-LYS-PHE;(MET(O)4,D-LYS8,PHE9)-ACTH (4-9);[MET(O)4, DLYS8, PHE9] ACTH (4-9), HUMAN;[MET(O)4, D-LYS8, PHE9]-ADRENOCORTICOTROPIC HORMONE (4-9);[MET(O)4, DLYS8, PHE9] ADRENOCORTICOTROPIC HORMONE (4-9), HUMAN;H-MET(O)-GLU-HIS-PHE-D-LYS-PHE-OH;(MET(O)4,D-LYS8,PHE9)-ADRENOCORTICOTROPI C HORMONE;4-(Methylsulfinyl)-L-2-aminobutanoyl-L-alpha-glutamyl-L-histidyl-L-phenylalanyl-D-lysyl-L-phenylalanine
- CAS NO:50913-93-4
- Molecular Formula: C40H55N9O10S
- Molecular Weight: 853.98
- EINECS: N/A
- Product Categories: N/A
- Mol File: 50913-93-4.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: 1.349
- Refractive Index: N/A
- Storage Temp.: -15°C
- Solubility: N/A
- CAS DataBase Reference: (MET(O)4,D-LYS8,PHE9)-ACTH (4-9)(CAS DataBase Reference)
- NIST Chemistry Reference: (MET(O)4,D-LYS8,PHE9)-ACTH (4-9)(50913-93-4)
- EPA Substance Registry System: (MET(O)4,D-LYS8,PHE9)-ACTH (4-9)(50913-93-4)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 50913-93-4(Hazardous Substances Data)
50913-93-4 Suppliers
Recommended suppliers
50913-93-4 Usage
Uses
Used in Pharmaceutical Research:(MET(O)4,D-LYS8,PHE9)-ACTH (4-9) is utilized as a research tool for investigating the role of ACTH in adrenal steroidogenesis and other biological processes. Its enhanced stability and bioactivity make it particularly useful for studying the mechanisms of action and potential therapeutic applications of ACTH-related treatments.
Used in Drug Development:
In the pharmaceutical industry, (MET(O)4,D-LYS8,PHE9)-ACTH (4-9) is employed as a lead compound for the development of new drugs targeting adrenal-related disorders. Its modified structure offers insights into the design of more effective and stable therapeutic agents that can modulate the activity of the adrenal glands.
Used in Diagnostic Applications:
(MET(O)4,D-LYS8,PHE9)-ACTH (4-9) serves as a diagnostic marker in clinical settings, aiding in the assessment of adrenal function and the diagnosis of conditions related to the hypothalamic-pituitary-adrenal (HPA) axis. Its ability to mimic the natural ACTH allows for more accurate testing and monitoring of adrenal responses.
Used in Cosmetics and Skincare:
In the cosmetics industry, (MET(O)4,D-LYS8,PHE9)-ACTH (4-9) may be used as an ingredient in skincare products for its potential anti-aging and skin-regenerative properties. The peptide's ability to influence biological processes could contribute to improved skin health and appearance.
Note: The uses listed are speculative based on the peptide's properties and potential applications in various fields. The actual uses may vary depending on further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 50913-93-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,9,1 and 3 respectively; the second part has 2 digits, 9 and 3 respectively.Calculate Digit Verification of CAS Registry Number 50913-93:
(7*5)+(6*0)+(5*9)+(4*1)+(3*3)+(2*9)+(1*3)=114
114 % 10 = 4
So 50913-93-4 is a valid CAS Registry Number.
50913-93-4Upstream product
50913-93-4Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 50913-93-4
(MET(O)4,D-LYS8,PHE9)-ACTH (4-9)
